Evidence map›Paper›PMID 28923054›Full record

ArticleMalaria journal2017

A novel method for extracting nucleic acids from dried blood spots for ultrasensitive detection of low-density Plasmodium falciparum and Plasmodium vivax infections.

Kayvan Zainabadi, Matthew Adams, Zay Yar Han, Hnin Wai Lwin, Kay Thwe Han, Amed Ouattara, Si Thura, Christopher V Plowe, Myaing M Nyunt

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 2 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 2 syntheses or guidelines pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. PCR Detection ofPathogens (Basel, Switzerland) · 2024
    Article
  13. Improved limit of detection for zoonoticmedRxiv : the preprint server for health sciences · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Kayvan ZainabadiDivision of Malaria Research, Institute for Global Health, University of Maryland School of Medicine, Baltimore, USA.
Matthew AdamsDivision of Malaria Research, Institute for Global Health, University of Maryland School of Medicine, Baltimore, USA.
Zay Yar HanDepartment of Medical Research, Ministry of Health and Sports, Yangon, Myanmar.
Hnin Wai LwinDepartment of Medical Research, Ministry of Health and Sports, Yangon, Myanmar.
Kay Thwe HanDepartment of Medical Research, Ministry of Health and Sports, Yangon, Myanmar.
Amed OuattaraDivision of Malaria Research, Institute for Global Health, University of Maryland School of Medicine, Baltimore, USA.
Si ThuraCommunity Partners International, Yangon, Myanmar.
Christopher V PloweDivision of Malaria Research, Institute for Global Health, University of Maryland School of Medicine, Baltimore, USA.
Myaing M NyuntDivision of Malaria Research, Institute for Global Health, University of Maryland School of Medicine, Baltimore, USA. mnyunt@som.umaryland.edu.ORCID 0000-0003-1460-0448
University of Maryland, Baltimore · USMinistry of Health and Sports · MM

Funding

Howard Hughes Medical Institute
6 · The paper itself

Abstract

backgroundGreater Mekong Subregion countries are committed to eliminating Plasmodium falciparum malaria by 2025. Current elimination interventions target infections at parasite densities that can be detected by standard microscopy or rapid diagnostic tests (RDTs). More sensitive detection methods have been developed to detect lower density "asymptomatic" infections that may represent an important transmission reservoir. These ultrasensitive polymerase chain reaction (usPCR) tests have been used to identify target populations for mass drug administration (MDA). To date, malaria usPCR tests have used either venous or capillary blood sampling, which entails complex sample collection, processing and shipping requirements. An ultrasensitive method performed on standard dried blood spots (DBS) would greatly facilitate the molecular surveillance studies needed for targeting elimination interventions.

methodsA highly sensitive method for detecting Plasmodium falciparum and P. vivax 18S ribosomal RNA from DBS was developed by empirically optimizing nucleic acid extraction conditions. The limit of detection (LoD) was determined using spiked DBS samples that were dried and stored under simulated field conditions. Further, to assess its utility for routine molecular surveillance, two cross-sectional surveys were performed in Myanmar during the wet and dry seasons.

resultsThe lower LoD of the DBS-based ultrasensitive assay was 20 parasites/mL for DBS collected on Whatman 3MM filter paper and 23 parasites/mL for Whatman 903 Protein Saver cards-equivalent to 1 parasite per 50 µL DBS. This is about 5000-fold more sensitive than standard RDTs and similar to the LoD of ≤16-22 parasites/mL reported for other ultrasensitive methods based on whole blood. In two cross-sectional surveys in Myanmar, nearly identical prevalence estimates were obtained from contemporaneous DBS samples and capillary blood samples collected during the wet and dry season.

conclusionsThe DBS-based ultrasensitive method described in this study shows equal sensitivity as previously described methods based on whole blood, both in its limit of detection and prevalence estimates in two field surveys. The reduced cost and complexity of this method will allow for the scale-up of surveillance studies to target MDA and other malaria elimination interventions, and help lead to a better understanding of the epidemiology of low-density malaria infections.

Indexed as

Asymptomatic InfectionsCross-Sectional StudiesDried Blood Spot TestingHumansMalaria, FalciparumMalaria, VivaxMyanmarPlasmodium falciparumPlasmodium vivaxPrevalenceRNA, ProtozoanRNA, Ribosomal, 18SRNA, ProtozoanRNA, Ribosomal, 18SAsymptomatic infectionDBSDiagnosticsDried blood spotLimits of detectionLow transmissionMalariaMalaria eliminationMolecular surveillanceMyanmarPlasmodium falciparumPlasmodium vivaxSoutheast AsiaUltrasensitive PCR

Identifiers

PMID28923054
PMCPMC5604154
OpenAlexW2755674774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.